The use of Butea superba (Roxb.) compared to sildenafil for treating erectile dysfunction
Cortés-González,Jeff R.; Arratia-Maqueo, Jorge A.; Gómez-Guerra, Lauro S.; Holmberg, Anders R.
https://doi.org/10.1111/j.1464-410X.2009.08748.x
Abstract
Study Type – Therapy (case control) Level of Evidence 3b
OBJECTIVE
To evaluate the effect of an extract of Butea superba (Roxb.) (BS) compared to sildenafil for treating erectile dysfunction (ED).
PATIENTS AND METHODS
An open label study was carried out among 32 men with organic ED to evaluate the response on the International Index of Erectile Function 5 (IIEF-5) to BS, a ‘natural health’ product (100 mg), compared to 50 mg of sildenafil (a phosphodiesterase-5 inhibitor). After a 1-week wash-out, responders to BS received either 100 mg starch or 100 mg of another batch of BS (double-blind).
RESULTS
Of the patients in the BS group, 27 (84%) responded positively, compared with 26 (81%) in the sildenafil group. When assessing the score alone, 12 (38%) had a better score after taking BS, compared to seven (22%) after sildenafil, and eight (25%) had the same score. The results were surprising and could not be repeated in the double-blind part of the study, where no effect of BS was recorded.
CONCLUSIONS
A ‘natural’ health product containing BS was more effective than sildenafil in the first part of the study, but in the second, using another batch of BS, the positive result could not be repeated and no effect was recorded. The conclusion is that the first preparation of BS was most likely blended with a phosphodiesterase-5 inhibitor, later confirmed by the supplier of BS (a natural health products company) after their own analysis.
References:
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61
Shokeir AA, Hussein MI. Sexual life in Pharaonic Egypt: towards a urological view. Int J Impot Res 2004; 16: 385–8
Seftel AD. Erectile dysfunction in the elderly. Epidemiology, etiology and approaches to treatment. J Urol 2003; 169: 1999–2007
Aytac IA, McKinley J, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50–6
Fazio L, Brock G. Erectile dysfunction: management update CMAJ 2004; 170: 1429–37
Mennickent S, Zurita L, Vega M, Villegas G. Características Del Uso De Sildenafil En Una Muestra De Pacientes A Nivel De Farmacias Comunitarias De Concepción. Chile Rev Méd Chile 2005; 133: 667–73
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of ED. New Eng J Med 1998; 338: 1397–404
Roengsumran S, Petsom A, Ngamrojanavanich N et al. Flavonoid and flavonoid glycoside from Butea superba Roxb. and their cAMP phosphodiesterase inhibitory activity. J Sci Res Chula University 2000;25: 1
Cherdshewasart W, Nimsakul N. Clinical trial of Butea Superba, an alternative herbal treatment for erectile dysfunction. Asian J Androl 2003; 5: 243–6
Tocharus C, Smitasiri Y, Jeenapongsa R. Butea superba Roxb. enhances penile erection in rats. Phytother Res 2006; 20: 484–9
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–26
Rhoden EL, Telöken C, Sogari PR, Vargas Souto CA. The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002; 14: 245–50
Montorsi F, Althof SE. Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction Urology 2004; 63: 762–6
Pongpanparadon A, Aritajat S, Saenphet K. The toxicology of Butea superba Roxb. Southeast Asian J Trop Med Public Health 2002; 33 (Suppl. 3): 155–8
Cherdshewasart W, Bhuntaku P, Panriansaen R, Dahlan W, Malaivijitnond S. Androgen disruption and toxicity tests of Butea superba Roxb., a traditional herb used for treatment of erectile dysfunction, in male rats. Maturitas 2008; 60: 131–7